These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671 [TBL] [Abstract][Full Text] [Related]
23. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives. Montserrat E; Bosch F; Rozman C J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185 [TBL] [Abstract][Full Text] [Related]
24. Prognostic markers and standard management of chronic lymphocytic leukemia. Stilgenbauer S Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745 [TBL] [Abstract][Full Text] [Related]
25. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications. Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978 [TBL] [Abstract][Full Text] [Related]
26. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome. Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941 [TBL] [Abstract][Full Text] [Related]
27. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans. Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254 [TBL] [Abstract][Full Text] [Related]
28. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. Fabris S; Mosca L; Cutrona G; Lionetti M; Agnelli L; Ciceri G; Barbieri M; Maura F; Matis S; Colombo M; Gentile M; Recchia AG; Anna Pesce E; Di Raimondo F; Musolino C; Gobbi M; Di Renzo N; Mauro FR; Brugiatelli M; Ilariucci F; Lipari MG; Angrilli F; Consoli U; Fragasso A; Molica S; Festini G; Vincelli I; Cortelezzi A; Federico M; Morabito F; Ferrarini M; Neri A Am J Hematol; 2013 Jan; 88(1):24-31. PubMed ID: 23044996 [TBL] [Abstract][Full Text] [Related]
29. Lymphocytosis and chronic lymphocytic leukaemia: investigation and management. Devi A; Thielemans L; Ladikou EE; Nandra TK; Chevassut T Clin Med (Lond); 2022 May; 22(3):225-229. PubMed ID: 35584829 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in chronic lymphocytic leukemia-what do we need to know? Cramer P; Hallek M Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983 [TBL] [Abstract][Full Text] [Related]
31. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852 [TBL] [Abstract][Full Text] [Related]
32. New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia. Gentile M; Mauro FR; Guarini A; Foà R Curr Opin Oncol; 2005 Nov; 17(6):597-604. PubMed ID: 16224240 [TBL] [Abstract][Full Text] [Related]
34. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force. Stauder R; Eichhorst B; Hamaker ME; Kaplanov K; Morrison VA; Österborg A; Poddubnaya I; Woyach JA; Shanafelt T; Smolej L; Ysebaert L; Goede V Ann Oncol; 2017 Feb; 28(2):218-227. PubMed ID: 27803007 [TBL] [Abstract][Full Text] [Related]
35. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study. Gentile M; Cutrona G; Mosca L; Matis S; Fabris S; Lionetti M; Ilariucci F; Zupo S; Musolino C; Levato L; Molica S; Di Raimondo F; Vincelli I; Di Rienzo N; Pesce EA; Angrilli F; Federico M; Neri A; Ferrarini M; Morabito F Am J Hematol; 2014 Jul; 89(7):743-50. PubMed ID: 24711230 [TBL] [Abstract][Full Text] [Related]
36. Present and future of personalized medicine in CLL. Montserrat E; Bauman T; Delgado J Best Pract Res Clin Haematol; 2016 Mar; 29(1):100-110. PubMed ID: 27742064 [TBL] [Abstract][Full Text] [Related]
37. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Shanafelt TD; Byrd JC; Call TG; Zent CS; Kay NE Ann Intern Med; 2006 Sep; 145(6):435-47. PubMed ID: 16983131 [TBL] [Abstract][Full Text] [Related]
38. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker? Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722 [TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in chronic lymphocytic leukemia. Hallek M; Kuhn-Hallek I; Emmerich B Leukemia; 1997 Apr; 11 Suppl 2():S4-13. PubMed ID: 9178831 [TBL] [Abstract][Full Text] [Related]
40. Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines. Molica S; Giannarelli D; Mirabelli R; Levato L; Gentile M; Lentini M; Morabito F Expert Rev Hematol; 2014 Oct; 7(5):691-5. PubMed ID: 25174547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]